Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pabst

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
The ISME Journal|July 13, 2023
Trichlorobacter ammonificans, a dedicated acetate-dependent ammonifier with a novel module for dissimilatory nitrate reduction to ammoniaDimitry Y Sorokin, Tamara V Tikhonova, Hanna Koch, et al.
Cell Reports|June 29, 2022
Full humanization of the glycolytic pathway in Saccharomyces cerevisiaeFrancine J Boonekamp, Ewout Knibbe, Marcel A Vieira-Lara, et al.
Elife|March 4, 2022
Cellular assays identify barriers impeding iron-sulfur enzyme activity in a non-native prokaryotic hostFrancesca D'Angelo, Elena Fernández-Fueyo, Pierre Simon Garcia, et al.
Frontiers in Pharmacology|July 5, 2022
Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced <i>in vivo</i> PerformanceNick Evans, Ruslan Grygorash, Paul Williams, et al.
Microbiome|May 23, 2025
Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomesRobert Heyer, Maximilian Wolf, Dirk Benndorf, et al.
Molecular Pharmaceutics|April 21, 2015
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody RatiosPenny Bryant, Martin Pabst, George Badescu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugatesMartin Pabst, William McDowell, Anaïs Manin, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
The ISME Journal|July 13, 2023
Trichlorobacter ammonificans, a dedicated acetate-dependent ammonifier with a novel module for dissimilatory nitrate reduction to ammoniaDimitry Y Sorokin, Tamara V Tikhonova, Hanna Koch, et al.
Cell Reports|June 29, 2022
Full humanization of the glycolytic pathway in Saccharomyces cerevisiaeFrancine J Boonekamp, Ewout Knibbe, Marcel A Vieira-Lara, et al.
Elife|March 4, 2022
Cellular assays identify barriers impeding iron-sulfur enzyme activity in a non-native prokaryotic hostFrancesca D'Angelo, Elena Fernández-Fueyo, Pierre Simon Garcia, et al.
Frontiers in Pharmacology|July 5, 2022
Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced <i>in vivo</i> PerformanceNick Evans, Ruslan Grygorash, Paul Williams, et al.
Microbiome|May 23, 2025
Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomesRobert Heyer, Maximilian Wolf, Dirk Benndorf, et al.
Molecular Pharmaceutics|April 21, 2015
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody RatiosPenny Bryant, Martin Pabst, George Badescu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugatesMartin Pabst, William McDowell, Anaïs Manin, et al.
Pageof 14